You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 4, April 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •eFigure and eTables
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Bipolar Disorder
 •Mood Disorders
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Genetic Disorders
 •Alert me on articles by topic

A Discriminating Messenger RNA Signature for Bipolar Disorder Formed by an Aberrant Expression of Inflammatory Genes in Monocytes

Roos C. Padmos, MD; Manon H. J. Hillegers, MD, PhD; Esther M. Knijff, MD, PhD; Ronald Vonk, MD; Anne Bouvy, MSc; Frank J. T. Staal, PhD; Dick de Ridder, PhD; Ralph W. Kupka, MD, PhD; Willem A. Nolen, MD, PhD; Hemmo A. Drexhage, MD, PhD

Arch Gen Psychiatry. 2008;65(4):395-407.

Context  Mood disturbances are associated with an activated inflammatory response system.

Objective  To identify a discriminating and coherent expression pattern of proinflammatory genes in monocytes of patients with bipolar disorder.

Design  A quantitative polymerase chain reaction (Q-PCR) case-control gene expression study on purified monocytes of bipolar patients, the offspring of bipolar patients, and healthy control participants after having selected 22 discriminating inflammatory genes using whole genome analyses.

Setting  Academic research setting in the Netherlands.

Patients  Forty-two bipolar patients with 25 healthy controls, 54 offspring of a bipolar parent (13 had a mood disorder and 3 developed one during follow-up), and 70 healthy children underwent Q-PCR.

Main Outcome Measure  Inflammatory gene expression levels in monocytes.

Results  We detected in the monocytes of bipolar patients a coherent mutually correlating set (signature) of 19 aberrantly expressed (P < .01) messenger RNAs of inflammatory (PDE4B, IL1B, IL6, TNF, TNFAIP3, PTGS2, and PTX3), trafficking (CCL2, CCL7, CCL20, CXCL2, CCR2, and CDC42), survival (BCL2A1 and EMP1), and mitogen-activated protein kinase pathway (MAPK6, DUSP2, NAB2, and ATF3) genes. Twenty-three of 42 bipolar patients (55%) had a positive signature test result vs 7 of 38 healthy controls (18%) (positive test result: positivity for PDE4B, ie, a messenger RNA 1 SD higher than the mean level found in healthy controls, plus 25% of the other genes with similar positive findings). Positive signature test results were also present in 11 of 13 offspring with a mood disorder (85%), 3 of 3 offspring developing a mood disorder (100%), and 17 of 38 euthymic offspring (45%) vs 13 of 70 healthy children (19%). Lithium carbonate and antipsychotic treatment downregulated the gene expression of most inflammatory genes.

Conclusions  The monocytes of a large proportion of bipolar patients and offspring of bipolar parents showed an inflammatory gene expression signature. This coherent set of genes opens new avenues for biomarker development with possibilities for disease prediction in individuals genetically at risk and for the subclassification of bipolar patients who could possibly benefit from anti-inflammatory treatment.


Author Affiliations: Department of Immunology, Erasmus Medical Center, Rotterdam (Drs Padmos, Knijff, Staal, and Drexhage and Ms Bouvy); Department of Child and Adolescent Psychiatry, University Medical Center Utrecht (Dr Hillegers), and Altrecht Institute for Mental Health Care (Dr Kupka), Utrecht; Reinier van Arkel group, ’s-Hertogenbosch (Dr Vonk); Department of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft (Dr de Ridder); and Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen (Dr Nolen), the Netherlands.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.